Thrombopoietin mimetics vs placebo
Incidence of bleeding events · Adult patients with myelodysplastic syndromes and thrombocytopenia
Thrombopoietin mimetics probably leads to lower incidence of bleeding events compared with placebo (moderate certainty).
1 finding from 1 review
- Thrombopoietin mimetics for patients with myelodysplastic syndromes 2017 · Cochrane Headline outcomes onlyRR 0.92 [0.86, 0.98]5 studies · 390 participantsModerate